BPC 157 has strong angiogenic potential, it acts protectively on endothelium, prevents and reverses thrombus formation after abdominal aorta anastomosis, affects many central disturbances (i.e., dopamine and 5-HT system), the NO-system (either Larginine and L-NAME effects), endothelin, acts as a free radical scavenger (counteracting CCl4-, paracetamol-, diclofenac-injuries) and exhibits neuroprotective properties
Cross-stream research framings have continued to expand the application bracket through novel investigation contexts
Based on these results, AKT1, TNF, STAT3, JUN, and EGFR were closely related to other targets in the PPI network, and presumably, they were identified as the most likely to be important potential targets against AD
Reported targets & pathways Angiogenesis and tissue-repair pathways (BPC-157) Actin-sequestering / cell-migration pathways (TB-500) Wound-healing signaling Tendon and muscle repair pathways Selected research Published studies on BPC-157 + TB-500 Blend Peer-reviewed references for further reading
Endotoxin testing is vital to confirm true biological pass marks in lyophilized peptides